FAQ
General
Data is encrypted, stored securely, and accessible only to a limited number of trained support staff. Users can delete their accounts and data permanently.
No, Mira doesn’t sell user data. Revenue comes from device and wand sales, and all data processes are HIPAA and GDPR-compliant.
All user data is encrypted both in transit and on our secure backend systems. Data is stored securely using AWS infrastructure and we comply with stringent regulations, including HIPAA—which ensures that protected health information (PHI) is handled safely—and GDPR, which upholds data protection standards for users within the European Union. Additionally, we have a comprehensive data breach response plan in place to proactively address any potential issues. Users maintain complete control over their data and can permanently delete their account and all associated data at any time. We do not share PHI with the government or any unauthorized third parties and never sell user data.
Yes, Mira products are HSA/FSA eligible items. Their HSA/FSA funds can be used after applying a provider discount code.
Test every other day during early and late phases, daily during the fertile window, and every two to three days in the luteal phase to conserve supplies.
Mira is not covered by standard insurance, but it is eligible for payment through FSA and HSA accounts. Patients can use their FSA/HSA funds to purchase Mira products after applying a provider discount code. Additionally, some fertility benefit programs, such as Carrot and Maven, may cover Mira expenses, so it’s worth checking if your patient has access to these benefits.The costs are as follows: $175 for the Max starter kit, and $63 per set of 20 max wands for additional testing, after applying provider discounts.
Yes, all partnership options are available for international providers.
Yes, you may choose any combination of the partnership options available, including discount codes, affiliate commissions, drop shipping, and/or bulk purchases.
Yes, patients can purchase directly, or providers can order in bulk. Credentials for the provider portal can be obtained by contacting our partnerships team here.
Providers who meet with the Mira team can access the free provider dashboard. Contact partnership@miracare.com for credentials.
Testing or Use of Device
Yes, Mira is available internationally. We offer worldwide shipping and have warehouses in the USA, the United Kingdom, France, the Netherlands, China, and Australia. Free shipping is available on orders over $169 USD. Shipping rates will be automatically calculated at checkout based on your location.
No, patients can purchase it directly from the website using your discount code or affiliate link. Bulk purchasing options are also available.
No, there is a single Mira analyzer that can measure all four hormones: E3G, LH, PdG, and FSH.
E3G (estrone 3-glucuronide, a urine metabolite of serum estradiol), LH, PdG (pregnanediol glucuronide, a urine metabolite of serum progesterone), and FSH.
Mira is an FDA-registered Class I medical device. It is designed for at-home use and does not require CLIA certification, as it is not a laboratory-based test.
While Mira is not “FDA-cleared” (a designation reserved for higher-risk diagnostic devices), it is compliant with FDA regulations for low-risk wellness and fertility monitoring tools. The technology used in Mira has been clinically validated and supported by peer-reviewed research.
Mira meets the highest standards for medical devices:
• ISO 13485 Certified: Ensuring top-tier medical device quality & compliance.
• MDSAP compliant: Meeting regulatory requirements across the US, Canada and Australia.
• FDA Registered: Compliant with U.S. medical device regulations for safety and efficacy.
Quanovate Tech, Inc. has been registered by Intertek, an MDSAP recognized auditing organization, as conforming to the requirements of: ISO 13485:2016
Australia: Therapeutic Goods (Medical Devices) Regulations, 2002, Schedule 3 Part 1(excluding Part 1.6)
Canada: Medical Devices Regulations – Part 1- SOR 98/282
United States: 21 CFR 820, 21 CFR 803, 21 CFR 806, 21 CFR 807 (Subparts A to D)
At this time, Mira does not integrate with other devices or platforms. However, we are open to exploring integration opportunities in the future. If you would like to see Mira integrate with a specific device or platform, we encourage you to reach out to the company you're interested in and request integration. We have initiated discussions with Heads Up Health, but integration is not yet available.
You can start testing immediately on any day of the cycle except during your heavy menstrual bleeding.
Collect your sample after your longest period of sleep, ensuring it is a concentrated sample by holding your urine for at least 4 hours while limiting oral fluid intake for at least 2 hours before the test. For best results, try to be consistent with your testing pattern.
For optimal results, collect your urine after the longest period of sleep, ideally after at least 4 hours. Test immediately after collection, as hormone metabolites start to break down over time. Consistency is crucial for tracking estrogen patterns and trends.
Yes, you can still use the Mira device without a smartphone. You will need to manually record your results on a log or chart, as the device will display the results directly on its screen.
We advise against switching wand types during a cycle because different wands (or different lots) can cause slight variations in E3G measurements. However, switching after ovulation is acceptable.
No, Mira wands are designed for single use only. However, our tests are recyclable and eco-friendly.
The urine is contained within the wand, secured by a cap, so the device doesn’t come into contact with urine so routine cleaning is necessary between uses. However, if you wish to clean the device for personal preference, you may do so. To clean your Mira analyzer, gently wipe the surface using a lint-free cloth lightly dampened with 70-75% alcohol. Be careful to avoid any liquid entering the interior of the device.
No, the analyzer is connected to a specific user's Mira app via Bluetooth. While you can reset the device for a new user (see instructions below), we cannot guarantee accurate results after multiple users.
To delete data from the analyzer, you will need to restore the analyzer to its factory settings. This option is available only when the analyzer is connected to the app. To do so, please follow these steps:
1. Navigate to Profile
2. Select My Devices
3. Choose Mira Analyzer
4. Tap Restore to Factory Settings
No, Mira has not been studied for use in pregnancy and therefore, patients should stop testing after a positive pregnancy test.
The battery life of the analyzer depends on the frequency of use and the number of test wands used. Typically, the battery lasts anywhere from several days to up to 2 weeks.
For optimal performance, we recommend regularly monitoring the battery level and charging as needed.
Yes, read our warranty policy and terms below.
Warranty Policy:
1. At Mira, we want you to have peace of mind when you use our products. That’s why we warrant Mira-branded products, including the Mira Monitor and Mira Basel Body Thermometer, Mira-branded accessories (“Mira Product”), and all other products that are sold by Mira (“Complementary Products”) against manufacturing defects in materials and workmanship for a period of 1 year starting from the date of the original purchase.
2. Mira requires the original receipt for warranty claims.
3. To commence the warranty process, kindly contact us. Include any relevant pictures or videos, and detail any troubleshooting steps you’ve already undertaken. This information enables us to provide you with prompt and effective assistance.
Warranty Terms:
1. If your Mira Product or Complementary Products covered by this warranty fails due to a manufacturing defect, Mira will, during the Warranty period:
◦ Repair the Mira Product or Complementary Products, including the Mira Monitor and Mira Basel Body Thermometer, without charge, using new or previously used genuine parts that have been tested and passed functional requirements.
◦ Replace Mira Product and/or Complementary Products, including the Mira Monitor and Mira Basal Body Thermometer, with a replacement product of the same model.
◦ Warranty excludes coverage for (i) normal wear and tear, including scratches and dents; (ii) consumable parts included in the Mira Product or Complementary Products, such as batteries, unless product damage has occurred due to a defect in materials or workmanship; (iii) damage resulting from your failure to use the Mira Product in accordance with the instructions accompanying the Mira Product or available at the website; (iv) damage resulting from an accident, flood, fire, misuse, or abuse; (v) damage resulting from service performed, or damage resulting from tampering with or alterations to the Mira Product, by anyone not authorized by Mira; or (vi) use of the Mira Product with any application or software other than the Mira Mobile App.
◦ Mira retains the exclusive right to repair or replace the Mira Product or Complementary Products, at its sole discretion.
◦ Warranty repairs and replacements have a new warranty which is the longer of 90 days or the balance of the original 1 year warranty.
Follow these steps:
Close and reopen the app. If the issue persists, write down today’s results and proceed.
Unpair and re-pair the device through the "My Devices" section in the Mira app.
Uninstall and reinstall the Mira app if needed.
Manually add results under "Chart View" using "Add New Measurement."
Contact Mira's VIP customer service at vipsupport@miracare.com for further assistance.
While our app isn’t currently available on the standard App Store in Australia, there’s a workaround to start using Mira. Here are the steps:
For our Apple users 🍏:
1. Start by downloading TestFlight. If you’re wondering, “What’s TestFlight?” it’s Apple’s official platform for trying out apps before they go live to the public. It’s totally safe, secure, and used by developers worldwide!
2. Once TestFlight is on your device, tap this link to access the Mira Fertility & Cycle Tracker beta: Mira for Apple. Note: this iOS app gives you the full span of functions the Mira App has.
And for our Android users 🤖:
Just tap on the link below to download the Mira app from Google Play. 👉 Mira for Android.
This is just a temporary solution to give you access to our app; there is no risk in using it. Our Privacy Policy is still relevant; no additional data will be collected by Apple while using these apps. We will update you once the Mira App is available in the App Store in Australia.
The menopause mode is available for anyone 35 years old and older who would like to monitor their menopausal transition. Since this is an optional feature it can be activated by going into your profile (top left-hand corner) and select “menopause” transitions”.
Historical Mira data is stored in cloud storage and can be accessed by the patient in their Mira app and accessed by the provider in the provider dashboard.
The Mira Analyzer can store up to 200+ test results without syncing. It's recommended to sync your data with the app whenever possible for analysis and tracking. Please note that any unsynced data will be lost if the analyzer is reset to its factory settings.
Encourage your patient to reach out to Mira's VIP customer service at vipsupport@miracare.com for priority assistance. To help expedite the process, suggest that they send a video and/or picture of the issue they are experiencing.
Gain access to the Miracare provider dashboard by emailing our team at partnership@miracare.com.
Educational Questions
Yes, providers can request discount codes or affiliate links to reduce costs for patients and earn commissions on referrals. Mira also provides a public discount code for social media or webinars.
Progesterone levels can fluctuate due to factors like timing of collection, hydration, or recent activity. Focus on trends over time rather than isolated measurements.
Contact Mira for personalized training or access their resource hub, which includes videos and case studies tailored for healthcare providers.
We are developing a provider course but for now, you can explore these resources:
Integrative Women's Health Institute- https://integrativewomenshealthinstitute.com/
FACTS- https://www.factsaboutfertility.org/cme-faq/
IIRRM- https://iirrm.org/
FEMM Health- https://femmhealth.org/professional-education/medical-training/
Institute for Menstrual Health
To ensure accurate results when using Mira for testing, it’s important to understand how the following medications and supplements may affect the data:
1. Methylene Blue
◦ Do not take Methylene Blue while using Mira for testing.
◦ Discontinue Methylene Blue 5-7 days prior to testing to avoid interference.
2. Biotin
◦ High doses of Biotin (5,000 mcg or more per day) can disrupt urine hormone tests, particularly affecting hCG levels in urine and TSH, T4, and T3 levels in blood.
◦ Biotin has a half-life of 2 hours, but its metabolites can remain in the body for up to 24 hours. Discontinue high-dose Biotin supplements at least 48 hours before testing.
3. Vitamin C
◦ Doses greater than 1,000 mg per day of Vitamin C may impact hormone metabolite results in urine.
4. Pregnenolone
◦ Pregnenolone supplementation can affect Mira results by increasing progesterone metabolites due to the first-pass effect, although it does not directly raise progesterone levels.
◦ To monitor endogenous hormones, discontinue oral or sublingual pregnenolone for 3 days before testing.
5. DHEA
◦ DHEA supplementation can also affect Mira results.
◦ To monitor endogenous hormones, discontinue DHEA at least 1 day before testing.
6. Other Medications, Supplements, and Interventions
◦ Other medications and supplements may also affect Mira data.
Please refer to our detailed protocols for specific guidelines.
Fluid intake and hydration status can influence data, as well as medications like Clomid. Kidney disorders may alter urine composition and affect accuracy.
No, creatinine correction is not necessary if patients follow fluid intake guidelines, as it does not significantly impact accuracy.
Mira is reliable and valid when used correctly. It tracks hormone trends accurately and align well with serum hormone levels, as demonstrated by clinical research. Internal checks and calibrations ensure consistent performance.
Additionally, Mira’s coefficient of variation (CV) falls within industry standards, and internal studies comparing Mira to the Abbott Architect i2000SR have shown a strong linear correlation.
Hormonal birth control typically suppresses ovulation, but some women may still ovulate and have menstrual cycles. Combined oral contraceptives typically suppress ovulation, which can result in non-ovulatory, non-menstrual bleeding cycles, breakthrough bleeding, or even amenorrhea. In contrast, progestin-only pills (POPs) may allow for the continuation of regular cycles.Mira can be useful for women experiencing symptoms they attribute to hormonal fluctuations or deprivation while using contraceptive methods that suppress ovulation. For example, if symptoms such as vaginal dryness, pain during sex, low mood, or low desire are present, Mira can help confirm low hormone levels and the absence of fluctuating LH/FSH, supporting the possibility of hormonal deprivation.If symptoms appear cyclical but Mira shows no hormonal fluctuations (as expected with ovulatory suppression), clinicians can help differentiate these symptoms from hormonal causes. Mira can also help identify background ovarian activity, whether it is regular, irregular, or resulting in successful ovulation. Some healthcare providers recommend that patients begin using the Mira monitor to track their hormone patterns before transitioning off birth control. This approach helps patients establish a testing routine and gain a clearer understanding of their hormonal changes both before and after discontinuing birth control. It provides valuable insights into their fertility and overall reproductive health throughout the transition period. See additional information here.
Beyond two years post-menopause, hormone levels are generally low and stable, making tracking with Mira likely unnecessary. However, using Mira to monitor hormone replacement therapy (HRT) during menopause is still being investigated.
Yes, several pilots and studies are currently underway related to perimenopause. Our perimenopause use case resources are here
Mira does not track xenoestrogens directly. However, if xenoestrogens lead to an increase in serum estradiol (E2) levels or contribute to estrogen dominance, Mira’s E3G levels will reflect this increase.
It is important to note that PdG is highly sensitive to improper testing techniques, so we strongly recommend that clients carefully follow the provided instructions to ensure accurate results. Anecdotal observations suggest that abnormal PdG levels during the follicular phase may occur in individuals with hormone imbalances, such as those with PCOS, although further research is ongoing. Additionally, a study has reported stress-induced increases in both progesterone and cortisol in naturally cycling women (reference). Currently, we do not consider elevated PdG levels in the follicular phase to require specific treatment.
To confirm an ovulatory event using Mira PdG, you can look for one of these two patterns:
Option 1- Three-Day Rise: Three consecutive days of rising PdG levels, with each day at least 1.25 times higher than the previous day after an LH surge.
Option 2 - Sustained Elevated PdG: Multiple PdG levels consistently higher than baseline following an LH surge.
For additional detail please refer to our interpretation guide.
While research involving Mira has shown a strong correlation between serum hormone levels and urinary metabolites, it's crucial to understand that they are not directly equivalent (see research here). Urinary metabolites and serum hormones are measured in different units and reflect a correlation rather than a direct equivalence. Urinary metabolites, which are a result of the metabolism of serum hormones, offer a delayed reflection of these hormones. While urinary metabolite levels may fluctuate, they generally align with the overall pattern of serum hormone levels. Therefore, instead of comparing specific data points, it's more effective to focus on trends over time. Many healthcare providers utilize a combined approach, employing continuous monitoring with devices like Mira to track trends and periodic serum tests to obtain precise snapshots of hormone levels at specific points in time. In conclusion, while Mira can be a valuable tool for monitoring hormone trends, it's important to remember that it's not a substitute for traditional serum hormone tests.
Mira uses fluorescent lateral flow immunoassay technology, which is more accurate and sensitive than the nano-gold technology used by other trackers (e.g., Proov, Inito). Fluorescent analyzers, like Mira, provide quantitative results preferred by providers. Read more here.
Mira offers several advantages over traditional dried urine testing, such as the Dutch test, by utilizing laboratory-grade immunofluorescence technology, providing immediate results, and enabling remote monitoring. These features make Mira a highly efficient and convenient option for tracking hormone levels and trends in real time. In contrast, Dutch requires a dried urine sample to be collected, mailed, and analyzed at the Dutch laboratory, which typically takes up to three weeks to return results. Additionally, Mira and Dutch use different sets of urine metabolites, which means their results cannot be directly compared.
While Mira can replace Dutch cycle mapping, it can also complement Dutch testing, which provides insights into adrenal function, organic acids, and metabolite pathways. For instance, Mira can help accurately time interventions and assessments, such as conducting a Dutch Complete test seven days after ovulation. This approach is more reliable than using a generic cycle day 21 result, as ovulation timing varies significantly between women. Testing seven days post-ovulation offers a more precise reflection of hormonal activity.
While Dutch offers a detailed snapshot of hormone levels, Mira's real-time monitoring and trend analysis provide continuous insights, making it particularly beneficial for ongoing interventions and personalized healthcare strategies.
General
Data is encrypted, stored securely, and accessible only to a limited number of trained support staff. Users can delete their accounts and data permanently.
No, Mira doesn’t sell user data. Revenue comes from device and wand sales, and all data processes are HIPAA and GDPR-compliant.
All user data is encrypted both in transit and on our secure backend systems. Data is stored securely using AWS infrastructure and we comply with stringent regulations, including HIPAA—which ensures that protected health information (PHI) is handled safely—and GDPR, which upholds data protection standards for users within the European Union. Additionally, we have a comprehensive data breach response plan in place to proactively address any potential issues. Users maintain complete control over their data and can permanently delete their account and all associated data at any time. We do not share PHI with the government or any unauthorized third parties and never sell user data.
Yes, Mira products are HSA/FSA eligible items. Their HSA/FSA funds can be used after applying a provider discount code.
Test every other day during early and late phases, daily during the fertile window, and every two to three days in the luteal phase to conserve supplies.
Mira is not covered by standard insurance, but it is eligible for payment through FSA and HSA accounts. Patients can use their FSA/HSA funds to purchase Mira products after applying a provider discount code. Additionally, some fertility benefit programs, such as Carrot and Maven, may cover Mira expenses, so it’s worth checking if your patient has access to these benefits.The costs are as follows: $175 for the Max starter kit, and $63 per set of 20 max wands for additional testing, after applying provider discounts.
Yes, all partnership options are available for international providers.
Yes, you may choose any combination of the partnership options available, including discount codes, affiliate commissions, drop shipping, and/or bulk purchases.
Yes, patients can purchase directly, or providers can order in bulk. Credentials for the provider portal can be obtained by contacting our partnerships team here.
Providers who meet with the Mira team can access the free provider dashboard. Contact partnership@miracare.com for credentials.
Testing or Use of Device
Yes, Mira is available internationally. We offer worldwide shipping and have warehouses in the USA, the United Kingdom, France, the Netherlands, China, and Australia. Free shipping is available on orders over $169 USD. Shipping rates will be automatically calculated at checkout based on your location.
No, patients can purchase it directly from the website using your discount code or affiliate link. Bulk purchasing options are also available.
No, there is a single Mira analyzer that can measure all four hormones: E3G, LH, PdG, and FSH.
E3G (estrone 3-glucuronide, a urine metabolite of serum estradiol), LH, PdG (pregnanediol glucuronide, a urine metabolite of serum progesterone), and FSH.
Mira is an FDA-registered Class I medical device. It is designed for at-home use and does not require CLIA certification, as it is not a laboratory-based test.
While Mira is not “FDA-cleared” (a designation reserved for higher-risk diagnostic devices), it is compliant with FDA regulations for low-risk wellness and fertility monitoring tools. The technology used in Mira has been clinically validated and supported by peer-reviewed research.
Mira meets the highest standards for medical devices:
• ISO 13485 Certified: Ensuring top-tier medical device quality & compliance.
• MDSAP compliant: Meeting regulatory requirements across the US, Canada and Australia.
• FDA Registered: Compliant with U.S. medical device regulations for safety and efficacy.
Quanovate Tech, Inc. has been registered by Intertek, an MDSAP recognized auditing organization, as conforming to the requirements of: ISO 13485:2016
Australia: Therapeutic Goods (Medical Devices) Regulations, 2002, Schedule 3 Part 1(excluding Part 1.6)
Canada: Medical Devices Regulations – Part 1- SOR 98/282
United States: 21 CFR 820, 21 CFR 803, 21 CFR 806, 21 CFR 807 (Subparts A to D)
At this time, Mira does not integrate with other devices or platforms. However, we are open to exploring integration opportunities in the future. If you would like to see Mira integrate with a specific device or platform, we encourage you to reach out to the company you're interested in and request integration. We have initiated discussions with Heads Up Health, but integration is not yet available.
You can start testing immediately on any day of the cycle except during your heavy menstrual bleeding.
Collect your sample after your longest period of sleep, ensuring it is a concentrated sample by holding your urine for at least 4 hours while limiting oral fluid intake for at least 2 hours before the test. For best results, try to be consistent with your testing pattern.
For optimal results, collect your urine after the longest period of sleep, ideally after at least 4 hours. Test immediately after collection, as hormone metabolites start to break down over time. Consistency is crucial for tracking estrogen patterns and trends.
Yes, you can still use the Mira device without a smartphone. You will need to manually record your results on a log or chart, as the device will display the results directly on its screen.
We advise against switching wand types during a cycle because different wands (or different lots) can cause slight variations in E3G measurements. However, switching after ovulation is acceptable.
No, Mira wands are designed for single use only. However, our tests are recyclable and eco-friendly.
The urine is contained within the wand, secured by a cap, so the device doesn’t come into contact with urine so routine cleaning is necessary between uses. However, if you wish to clean the device for personal preference, you may do so. To clean your Mira analyzer, gently wipe the surface using a lint-free cloth lightly dampened with 70-75% alcohol. Be careful to avoid any liquid entering the interior of the device.
No, the analyzer is connected to a specific user's Mira app via Bluetooth. While you can reset the device for a new user (see instructions below), we cannot guarantee accurate results after multiple users.
To delete data from the analyzer, you will need to restore the analyzer to its factory settings. This option is available only when the analyzer is connected to the app. To do so, please follow these steps:
1. Navigate to Profile
2. Select My Devices
3. Choose Mira Analyzer
4. Tap Restore to Factory Settings
No, Mira has not been studied for use in pregnancy and therefore, patients should stop testing after a positive pregnancy test.
The battery life of the analyzer depends on the frequency of use and the number of test wands used. Typically, the battery lasts anywhere from several days to up to 2 weeks.
For optimal performance, we recommend regularly monitoring the battery level and charging as needed.
Yes, read our warranty policy and terms below.
Warranty Policy:
1. At Mira, we want you to have peace of mind when you use our products. That’s why we warrant Mira-branded products, including the Mira Monitor and Mira Basel Body Thermometer, Mira-branded accessories (“Mira Product”), and all other products that are sold by Mira (“Complementary Products”) against manufacturing defects in materials and workmanship for a period of 1 year starting from the date of the original purchase.
2. Mira requires the original receipt for warranty claims.
3. To commence the warranty process, kindly contact us. Include any relevant pictures or videos, and detail any troubleshooting steps you’ve already undertaken. This information enables us to provide you with prompt and effective assistance.
Warranty Terms:
1. If your Mira Product or Complementary Products covered by this warranty fails due to a manufacturing defect, Mira will, during the Warranty period:
◦ Repair the Mira Product or Complementary Products, including the Mira Monitor and Mira Basel Body Thermometer, without charge, using new or previously used genuine parts that have been tested and passed functional requirements.
◦ Replace Mira Product and/or Complementary Products, including the Mira Monitor and Mira Basal Body Thermometer, with a replacement product of the same model.
◦ Warranty excludes coverage for (i) normal wear and tear, including scratches and dents; (ii) consumable parts included in the Mira Product or Complementary Products, such as batteries, unless product damage has occurred due to a defect in materials or workmanship; (iii) damage resulting from your failure to use the Mira Product in accordance with the instructions accompanying the Mira Product or available at the website; (iv) damage resulting from an accident, flood, fire, misuse, or abuse; (v) damage resulting from service performed, or damage resulting from tampering with or alterations to the Mira Product, by anyone not authorized by Mira; or (vi) use of the Mira Product with any application or software other than the Mira Mobile App.
◦ Mira retains the exclusive right to repair or replace the Mira Product or Complementary Products, at its sole discretion.
◦ Warranty repairs and replacements have a new warranty which is the longer of 90 days or the balance of the original 1 year warranty.
Follow these steps:
Close and reopen the app. If the issue persists, write down today’s results and proceed.
Unpair and re-pair the device through the "My Devices" section in the Mira app.
Uninstall and reinstall the Mira app if needed.
Manually add results under "Chart View" using "Add New Measurement."
Contact Mira's VIP customer service at vipsupport@miracare.com for further assistance.
While our app isn’t currently available on the standard App Store in Australia, there’s a workaround to start using Mira. Here are the steps:
For our Apple users 🍏:
1. Start by downloading TestFlight. If you’re wondering, “What’s TestFlight?” it’s Apple’s official platform for trying out apps before they go live to the public. It’s totally safe, secure, and used by developers worldwide!
2. Once TestFlight is on your device, tap this link to access the Mira Fertility & Cycle Tracker beta: Mira for Apple. Note: this iOS app gives you the full span of functions the Mira App has.
And for our Android users 🤖:
Just tap on the link below to download the Mira app from Google Play. 👉 Mira for Android.
This is just a temporary solution to give you access to our app; there is no risk in using it. Our Privacy Policy is still relevant; no additional data will be collected by Apple while using these apps. We will update you once the Mira App is available in the App Store in Australia.
The menopause mode is available for anyone 35 years old and older who would like to monitor their menopausal transition. Since this is an optional feature it can be activated by going into your profile (top left-hand corner) and select “menopause” transitions”.
Historical Mira data is stored in cloud storage and can be accessed by the patient in their Mira app and accessed by the provider in the provider dashboard.
The Mira Analyzer can store up to 200+ test results without syncing. It's recommended to sync your data with the app whenever possible for analysis and tracking. Please note that any unsynced data will be lost if the analyzer is reset to its factory settings.
Encourage your patient to reach out to Mira's VIP customer service at vipsupport@miracare.com for priority assistance. To help expedite the process, suggest that they send a video and/or picture of the issue they are experiencing.
Gain access to the Miracare provider dashboard by emailing our team at partnership@miracare.com.
Educational Questions
Yes, providers can request discount codes or affiliate links to reduce costs for patients and earn commissions on referrals. Mira also provides a public discount code for social media or webinars.
Progesterone levels can fluctuate due to factors like timing of collection, hydration, or recent activity. Focus on trends over time rather than isolated measurements.
Contact Mira for personalized training or access their resource hub, which includes videos and case studies tailored for healthcare providers.
We are developing a provider course but for now, you can explore these resources:
Integrative Women's Health Institute- https://integrativewomenshealthinstitute.com/
FACTS- https://www.factsaboutfertility.org/cme-faq/
IIRRM- https://iirrm.org/
FEMM Health- https://femmhealth.org/professional-education/medical-training/
Institute for Menstrual Health
To ensure accurate results when using Mira for testing, it’s important to understand how the following medications and supplements may affect the data:
1. Methylene Blue
◦ Do not take Methylene Blue while using Mira for testing.
◦ Discontinue Methylene Blue 5-7 days prior to testing to avoid interference.
2. Biotin
◦ High doses of Biotin (5,000 mcg or more per day) can disrupt urine hormone tests, particularly affecting hCG levels in urine and TSH, T4, and T3 levels in blood.
◦ Biotin has a half-life of 2 hours, but its metabolites can remain in the body for up to 24 hours. Discontinue high-dose Biotin supplements at least 48 hours before testing.
3. Vitamin C
◦ Doses greater than 1,000 mg per day of Vitamin C may impact hormone metabolite results in urine.
4. Pregnenolone
◦ Pregnenolone supplementation can affect Mira results by increasing progesterone metabolites due to the first-pass effect, although it does not directly raise progesterone levels.
◦ To monitor endogenous hormones, discontinue oral or sublingual pregnenolone for 3 days before testing.
5. DHEA
◦ DHEA supplementation can also affect Mira results.
◦ To monitor endogenous hormones, discontinue DHEA at least 1 day before testing.
6. Other Medications, Supplements, and Interventions
◦ Other medications and supplements may also affect Mira data.
Please refer to our detailed protocols for specific guidelines.
Fluid intake and hydration status can influence data, as well as medications like Clomid. Kidney disorders may alter urine composition and affect accuracy.
No, creatinine correction is not necessary if patients follow fluid intake guidelines, as it does not significantly impact accuracy.
Mira is reliable and valid when used correctly. It tracks hormone trends accurately and align well with serum hormone levels, as demonstrated by clinical research. Internal checks and calibrations ensure consistent performance.
Additionally, Mira’s coefficient of variation (CV) falls within industry standards, and internal studies comparing Mira to the Abbott Architect i2000SR have shown a strong linear correlation.
Hormonal birth control typically suppresses ovulation, but some women may still ovulate and have menstrual cycles. Combined oral contraceptives typically suppress ovulation, which can result in non-ovulatory, non-menstrual bleeding cycles, breakthrough bleeding, or even amenorrhea. In contrast, progestin-only pills (POPs) may allow for the continuation of regular cycles.Mira can be useful for women experiencing symptoms they attribute to hormonal fluctuations or deprivation while using contraceptive methods that suppress ovulation. For example, if symptoms such as vaginal dryness, pain during sex, low mood, or low desire are present, Mira can help confirm low hormone levels and the absence of fluctuating LH/FSH, supporting the possibility of hormonal deprivation.If symptoms appear cyclical but Mira shows no hormonal fluctuations (as expected with ovulatory suppression), clinicians can help differentiate these symptoms from hormonal causes. Mira can also help identify background ovarian activity, whether it is regular, irregular, or resulting in successful ovulation. Some healthcare providers recommend that patients begin using the Mira monitor to track their hormone patterns before transitioning off birth control. This approach helps patients establish a testing routine and gain a clearer understanding of their hormonal changes both before and after discontinuing birth control. It provides valuable insights into their fertility and overall reproductive health throughout the transition period. See additional information here.
Beyond two years post-menopause, hormone levels are generally low and stable, making tracking with Mira likely unnecessary. However, using Mira to monitor hormone replacement therapy (HRT) during menopause is still being investigated.
Yes, several pilots and studies are currently underway related to perimenopause. Our perimenopause use case resources are here
Mira does not track xenoestrogens directly. However, if xenoestrogens lead to an increase in serum estradiol (E2) levels or contribute to estrogen dominance, Mira’s E3G levels will reflect this increase.
It is important to note that PdG is highly sensitive to improper testing techniques, so we strongly recommend that clients carefully follow the provided instructions to ensure accurate results. Anecdotal observations suggest that abnormal PdG levels during the follicular phase may occur in individuals with hormone imbalances, such as those with PCOS, although further research is ongoing. Additionally, a study has reported stress-induced increases in both progesterone and cortisol in naturally cycling women (reference). Currently, we do not consider elevated PdG levels in the follicular phase to require specific treatment.
To confirm an ovulatory event using Mira PdG, you can look for one of these two patterns:
Option 1- Three-Day Rise: Three consecutive days of rising PdG levels, with each day at least 1.25 times higher than the previous day after an LH surge.
Option 2 - Sustained Elevated PdG: Multiple PdG levels consistently higher than baseline following an LH surge.
For additional detail please refer to our interpretation guide.
While research involving Mira has shown a strong correlation between serum hormone levels and urinary metabolites, it's crucial to understand that they are not directly equivalent (see research here). Urinary metabolites and serum hormones are measured in different units and reflect a correlation rather than a direct equivalence. Urinary metabolites, which are a result of the metabolism of serum hormones, offer a delayed reflection of these hormones. While urinary metabolite levels may fluctuate, they generally align with the overall pattern of serum hormone levels. Therefore, instead of comparing specific data points, it's more effective to focus on trends over time. Many healthcare providers utilize a combined approach, employing continuous monitoring with devices like Mira to track trends and periodic serum tests to obtain precise snapshots of hormone levels at specific points in time. In conclusion, while Mira can be a valuable tool for monitoring hormone trends, it's important to remember that it's not a substitute for traditional serum hormone tests.
Mira uses fluorescent lateral flow immunoassay technology, which is more accurate and sensitive than the nano-gold technology used by other trackers (e.g., Proov, Inito). Fluorescent analyzers, like Mira, provide quantitative results preferred by providers. Read more here.
Mira offers several advantages over traditional dried urine testing, such as the Dutch test, by utilizing laboratory-grade immunofluorescence technology, providing immediate results, and enabling remote monitoring. These features make Mira a highly efficient and convenient option for tracking hormone levels and trends in real time. In contrast, Dutch requires a dried urine sample to be collected, mailed, and analyzed at the Dutch laboratory, which typically takes up to three weeks to return results. Additionally, Mira and Dutch use different sets of urine metabolites, which means their results cannot be directly compared.
While Mira can replace Dutch cycle mapping, it can also complement Dutch testing, which provides insights into adrenal function, organic acids, and metabolite pathways. For instance, Mira can help accurately time interventions and assessments, such as conducting a Dutch Complete test seven days after ovulation. This approach is more reliable than using a generic cycle day 21 result, as ovulation timing varies significantly between women. Testing seven days post-ovulation offers a more precise reflection of hormonal activity.
While Dutch offers a detailed snapshot of hormone levels, Mira's real-time monitoring and trend analysis provide continuous insights, making it particularly beneficial for ongoing interventions and personalized healthcare strategies.
Contact our Support Team
Book a meeting with
Rose
Get support integrating Mira, interpreting charts, and recommending it to the right patients.
Book a meeting with
Eva
Get support integrating Mira, interpreting charts, and recommending it to the right patients.
Book a meeting with
Silva
Get help with the Provider Dashboard, partnerships, affiliate signup, and technical issues.